<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   349
  </number>
  <updateDate>
   2023-01-11T13:43:34Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:43:34Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-01-19
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 10 (Tuesday, January 19, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Ms. KUSTER:H.R. 349.Congress has the power to enact this legislation pursuantto the following:Article I Section 8, Clause 1 of the United StatesConstitution, the Taxing and Spending Clause: ``The Congressshall have Power To lay and collect Taxes, Duties, Impostsand Excises, to pay the Debts and provide for the commonDefense and general Welfare of the United States . . .''[Page H203]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-02-02T15:18:52Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-01-19T18:01:05Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <actions>
   <item>
    <actionDate>
     2021-02-05
    </actionDate>
    <text>
     Sponsor introductory remarks on measure. (CR H393)
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     B00100
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-02-02
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-01-19
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-01-19
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-01-19
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     K000382
    </bioguideId>
    <fullName>
     Rep. Kuster, Ann M. [D-NH-2]
    </fullName>
    <firstName>
     Ann
    </firstName>
    <lastName>
     Kuster
    </lastName>
    <party>
     D
    </party>
    <state>
     NH
    </state>
    <middleName>
     M.
    </middleName>
    <district>
     2
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     J000294
    </bioguideId>
    <fullName>
     Rep. Jeffries, Hakeem S. [D-NY-8]
    </fullName>
    <firstName>
     Hakeem
    </firstName>
    <lastName>
     Jeffries
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <middleName>
     S.
    </middleName>
    <district>
     8
    </district>
    <sponsorshipDate>
     2021-01-19
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     W000788
    </bioguideId>
    <fullName>
     Rep. Williams, Nikema [D-GA-5]
    </fullName>
    <firstName>
     Nikema
    </firstName>
    <lastName>
     Williams
    </lastName>
    <party>
     D
    </party>
    <state>
     GA
    </state>
    <district>
     5
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001285
    </bioguideId>
    <fullName>
     Rep. Brownley, Julia [D-CA-26]
    </fullName>
    <firstName>
     Julia
    </firstName>
    <lastName>
     Brownley
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     26
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001303
    </bioguideId>
    <fullName>
     Rep. Blunt Rochester, Lisa [D-DE-At Large]
    </fullName>
    <firstName>
     Lisa
    </firstName>
    <lastName>
     Blunt Rochester
    </lastName>
    <party>
     D
    </party>
    <state>
     DE
    </state>
    <district>
     0
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     T000482
    </bioguideId>
    <fullName>
     Rep. Trahan, Lori [D-MA-3]
    </fullName>
    <firstName>
     Lori
    </firstName>
    <lastName>
     Trahan
    </lastName>
    <party>
     D
    </party>
    <state>
     MA
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001159
    </bioguideId>
    <fullName>
     Rep. Strickland, Marilyn [D-WA-10]
    </fullName>
    <firstName>
     Marilyn
    </firstName>
    <lastName>
     Strickland
    </lastName>
    <party>
     D
    </party>
    <state>
     WA
    </state>
    <district>
     10
    </district>
    <sponsorshipDate>
     2021-02-02
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001216
    </bioguideId>
    <fullName>
     Rep. Schrier, Kim [D-WA-8]
    </fullName>
    <firstName>
     Kim
    </firstName>
    <lastName>
     Schrier
    </lastName>
    <party>
     D
    </party>
    <state>
     WA
    </state>
    <district>
     8
    </district>
    <sponsorshipDate>
     2021-02-02
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     F000462
    </bioguideId>
    <fullName>
     Rep. Frankel, Lois [D-FL-21]
    </fullName>
    <firstName>
     Lois
    </firstName>
    <lastName>
     Frankel
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <district>
     21
    </district>
    <sponsorshipDate>
     2021-02-02
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001185
    </bioguideId>
    <fullName>
     Rep. Sewell, Terri A. [D-AL-7]
    </fullName>
    <firstName>
     Terri
    </firstName>
    <lastName>
     Sewell
    </lastName>
    <party>
     D
    </party>
    <state>
     AL
    </state>
    <middleName>
     A.
    </middleName>
    <district>
     7
    </district>
    <sponsorshipDate>
     2021-02-02
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     K000381
    </bioguideId>
    <fullName>
     Rep. Kilmer, Derek [D-WA-6]
    </fullName>
    <firstName>
     Derek
    </firstName>
    <lastName>
     Kilmer
    </lastName>
    <party>
     D
    </party>
    <state>
     WA
    </state>
    <district>
     6
    </district>
    <sponsorshipDate>
     2021-02-24
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000627
    </bioguideId>
    <fullName>
     Rep. Demings, Val Butler [D-FL-10]
    </fullName>
    <firstName>
     Val
    </firstName>
    <lastName>
     Demings
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <middleName>
     Butler
    </middleName>
    <district>
     10
    </district>
    <sponsorshipDate>
     2021-02-24
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Cardiovascular and respiratory health
     </name>
    </item>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Emergency medical services and trauma care
     </name>
    </item>
    <item>
     <name>
      Health promotion and preventive care
     </name>
    </item>
    <item>
     <name>
      Health technology, devices, supplies
     </name>
    </item>
    <item>
     <name>
      Immunology and vaccination
     </name>
    </item>
    <item>
     <name>
      Infectious and parasitic diseases
     </name>
    </item>
    <item>
     <name>
      Manufacturing
     </name>
    </item>
    <item>
     <name>
      Public contracts and procurement
     </name>
    </item>
    <item>
     <name>
      Research and development
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-01-19
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-05-17T18:11:45Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Coronavirus Vaccine and Therapeutic Development Act of 2021&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill directs the Department of Health and Human Services (HHS) to increase the supply of vaccines and medical products that prevent or control COVID-19 (i.e., coronavirus disease 2019). To increase supplies, HHS must, as appropriate, award grants and enter other transactions to expand relevant research, procurement, and production activities.&lt;/p&gt; &lt;p&gt;HHS must report to Congress on these actions. The report must assess and detail plans to enhance the supply chain and manufacturing capacity for the vaccines and products. It must also include plans to support domestic and international vaccination programs.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Coronavirus Vaccine and Therapeutic Development Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Coronavirus Vaccine and Therapeutic Development Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To direct the Secretary of Health and Human Services to award contracts, grants, and cooperative agreements to expand and enhance capacity for manufacturing covered products to prevent and control the spread of SARS-CoV-2 and COVID-19.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Coronavirus Vaccine and Therapeutic Development Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-01-19T05:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr349ih/xml/BILLS-117hr349ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-02-05
   </actionDate>
   <text>
    Sponsor introductory remarks on measure. (CR H393)
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

B00100
2021-02-05
9
Library of Congress
Sponsor introductory remarks on measure. (CR H393)
IntroReferral
2021-02-02
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-01-19
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-01-19
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-01-19
9
Library of Congress
Introduced in House
IntroReferral
2021-01-19T18:01:05Z
Referred to
House
Energy and Commerce Committee
2021-02-02T15:18:52Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
J000294
8
Hakeem
Rep. Jeffries, Hakeem S. [D-NY-8]
Jeffries
S.
D
2021-01-19
NY
W000788
5
Nikema
Rep. Williams, Nikema [D-GA-5]
Williams
D
2021-01-28
GA
B001285
26
Julia
Rep. Brownley, Julia [D-CA-26]
Brownley
D
2021-01-28
CA
B001303
0
Lisa
Rep. Blunt Rochester, Lisa [D-DE-At Large]
Blunt Rochester
D
2021-01-28
DE
T000482
3
Lori
Rep. Trahan, Lori [D-MA-3]
Trahan
D
2021-01-28
MA
S001159
10
Marilyn
Rep. Strickland, Marilyn [D-WA-10]
Strickland
D
2021-02-02
WA
S001216
8
Kim
Rep. Schrier, Kim [D-WA-8]
Schrier
D
2021-02-02
WA
F000462
21
Lois
Rep. Frankel, Lois [D-FL-21]
Frankel
D
2021-02-02
FL
S001185
7
Terri
Rep. Sewell, Terri A. [D-AL-7]
Sewell
A.
D
2021-02-02
AL
K000381
6
Derek
Rep. Kilmer, Derek [D-WA-6]
Kilmer
D
2021-02-24
WA
D000627
10
Val
Rep. Demings, Val Butler [D-FL-10]
Demings
Butler
D
2021-02-24
FL
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-01-19
2021-02-05
Sponsor introductory remarks on measure. (CR H393)
House
Health
K000382
2
Ann
Rep. Kuster, Ann M. [D-NH-2]
N
Kuster
M.
D
NH
Cardiovascular and respiratory health Congressional oversight Emergency medical services and trauma care Health promotion and preventive care Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Manufacturing Public contracts and procurement Research and development
2021-01-19
Introduced in House
 <p><b>Coronavirus Vaccine and Therapeutic Development Act of 2021</b></p> <p>This bill directs the Department of Health and Human Services (HHS) to increase the supply of vaccines and medical products that prevent or control COVID-19 (i.e., coronavirus disease 2019). To increase supplies, HHS must, as appropriate, award grants and enter other transactions to expand relevant research, procurement, and production activities.</p> <p>HHS must report to Congress on these actions. The report must assess and detail plans to enhance the supply chain and manufacturing capacity for the vaccines and products. It must also include plans to support domestic and international vaccination programs.</p>
2021-05-17T18:11:45Z
00
2021-01-19T05:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr349ih/xml/BILLS-117hr349ih.xml
Coronavirus Vaccine and Therapeutic Development Act of 2021
Coronavirus Vaccine and Therapeutic Development Act of 2021
Display Title
IH
Introduced in House
To direct the Secretary of Health and Human Services to award contracts, grants, and cooperative agreements to expand and enhance capacity for manufacturing covered products to prevent and control the spread of SARS-CoV-2 and COVID-19.
Official Title as Introduced
IH
Introduced in House
Coronavirus Vaccine and Therapeutic Development Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:43:34Z
2023-01-11T13:43:34Z
3.0.0
B00100
2021-02-05
9
Library of Congress
Sponsor introductory remarks on measure. (CR H393)
IntroReferral
2021-02-02
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-01-19
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-01-19
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-01-19
9
Library of Congress
Introduced in House
IntroReferral
K000382
2
Ann
Rep. Kuster, Ann M. [D-NH-2]
N
Kuster
M.
D
NH
J000294
8
Hakeem
Rep. Jeffries, Hakeem S. [D-NY-8]
Jeffries
S.
D
2021-01-19
NY
W000788
5
Nikema
Rep. Williams, Nikema [D-GA-5]
Williams
D
2021-01-28
GA
B001285
26
Julia
Rep. Brownley, Julia [D-CA-26]
Brownley
D
2021-01-28
CA
B001303
0
Lisa
Rep. Blunt Rochester, Lisa [D-DE-At Large]
Blunt Rochester
D
2021-01-28
DE
T000482
3
Lori
Rep. Trahan, Lori [D-MA-3]
Trahan
D
2021-01-28
MA
S001159
10
Marilyn
Rep. Strickland, Marilyn [D-WA-10]
Strickland
D
2021-02-02
WA
S001216
8
Kim
Rep. Schrier, Kim [D-WA-8]
Schrier
D
2021-02-02
WA
F000462
21
Lois
Rep. Frankel, Lois [D-FL-21]
Frankel
D
2021-02-02
FL
S001185
7
Terri
Rep. Sewell, Terri A. [D-AL-7]
Sewell
A.
D
2021-02-02
AL
K000381
6
Derek
Rep. Kilmer, Derek [D-WA-6]
Kilmer
D
2021-02-24
WA
D000627
10
Val
Rep. Demings, Val Butler [D-FL-10]
Demings
Butler
D
2021-02-24
FL
Cardiovascular and respiratory health Congressional oversight Emergency medical services and trauma care Health promotion and preventive care Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Manufacturing Public contracts and procurement Research and development
2021-01-19
Introduced in House
 <p><b>Coronavirus Vaccine and Therapeutic Development Act of 2021</b></p> <p>This bill directs the Department of Health and Human Services (HHS) to increase the supply of vaccines and medical products that prevent or control COVID-19 (i.e., coronavirus disease 2019). To increase supplies, HHS must, as appropriate, award grants and enter other transactions to expand relevant research, procurement, and production activities.</p> <p>HHS must report to Congress on these actions. The report must assess and detail plans to enhance the supply chain and manufacturing capacity for the vaccines and products. It must also include plans to support domestic and international vaccination programs.</p>
2021-05-17T18:11:45Z
00
Coronavirus Vaccine and Therapeutic Development Act of 2021
Coronavirus Vaccine and Therapeutic Development Act of 2021
Display Title
IH
Introduced in House
To direct the Secretary of Health and Human Services to award contracts, grants, and cooperative agreements to expand and enhance capacity for manufacturing covered products to prevent and control the spread of SARS-CoV-2 and COVID-19.
Official Title as Introduced
IH
Introduced in House
Coronavirus Vaccine and Therapeutic Development Act of 2021
Short Title(s) as Introduced
2021-02-05
Sponsor introductory remarks on measure. (CR H393)